Bioavailability of lycopene

Authors

  • Bettina MORITZ Universidade Federal de Santa Catarina
  • Vera Lúcia Cardoso TRAMONTE Universidade Federal de Santa Catarina

Keywords:

biological availability, lycopene, lycopersicon esculentum

Abstract

This review collets several papers that evaluated the factors that influence the bioavailability of licopene, as
well as the food sources of this nutrient and the recommendation for ingestion of this carothenoid. To achieve
de objectives of the study, a bibliographic research of the last fifteen years was made by access to the Medline
(National Library of Medicine, USA) and Lilacs (Bireme, Brazil) databases, in english and portuguese, using as themes licopene, carothenoids and bioavailability. Lycopene is a carothenoid with no provitamin A activity, but is a strong antioxidant agent, being such function possibly responsible for contribution for the reduction the risks of developing cancer and other chronicle disease. This nutrient is found in a limited number of foods, and yet, the organism is unable to sinthetize it, it is obtained exclusively from the diet. Licopene ingestion suggest amount varies from 4 to 35mg/day. Studies demonstrate that there are many factors that can interfere in lycopene bioavailability, such as intestinal absorption; amount of lycopene in the source food; its presentation (isomers and synthetics); the presence of food matrix; presence of other nutrients in the meal (fat, fiber, other carothenoids, among others); use of drugs; food processing; besides the biological individuality and nutricional state os the individual. Studies about lycopene bioavailability have been developed over tomato and its products, most times, because that is the most frequently consumed. Study development emphasized the importance of the better way of absorption of this nutrient, being this relevant to the prevention of various diseases. 

References

Khachik F, Carvalho L, Bernstein PS, Muir GJ, Zhao DY, Katz NB. Chemistry, distribuition, and metabolism of tomato carotenoids and their impact on human health. Exp Biol Med. 2002; 227(10):845-51.

McClain RM, Bausch J. Summary of safety studies conducted with synthetic lycopene. Regul Toxicol Pharmacol. 2003; 37(2):274-85.

Bramley PM. Is lycopene beneficial to human helth? Phytochemistry. 2000; 54(3):233-6.

Lugasi A, Hovarie J, Biro L, Brandt S, Helyes L. Factors influencing lycopene content of foods, and lycopene of Hungarian population. Nutr Res. 2003; 23:1035-44.

Nunes LI, Mercadante AZ. Obtenção de cristais de licopeno a partir de descarte de tomate. Cienc Tecnol Aliment. 2004; 24(3):440-7.

Rao AV, Shen H. Effect of low dose lycopene intake on lycopene bioavaliability and oxidative stress. Nutr Res. 2002; 22:1125-31.

Shami NJI, Moreira EAM. Licopeno como agente antioxidante. Rev Nutr. 2004; 17(2):227-36.

Johnson-Down L. Food habits of Canadians: lutein and lycopene intake in the Canadian population. JADA. 2002; 102(7):9988-91.

Paiva SAR, Russel RM. beta-carotene and other carotenoids as antioxidants. J Am Coll Nutr. 1999; 18(5):426-33.

Arab L, Steck S. Lycopene and cardiovascular disease. Am J Clin Nutr. 2000; 71(Suppl): 1691S-5S.

Rao AV, Agarwal S. Role of oxidant lycopene in cancer and heart disease. J Am Coll Nutr. 2000; 19(5):563-9.

Nguyen ML, Schwartz SJ. Chemical and biological properties. Food Technol. 1999; 53(2):38-45.

Giovannucci E. Tomatoes, tomato-based products, lycopene, and cancer: review of the epidemiologic literature. J Natl Cancer Inst. 1999; 91(4):317-31.

Matioli G, Rodriguez-Amaya DB. Microencapsulação do licopeno com ciclodextrinas. Cienc Tecnol Aliment. 2003; 23:102-5.

Clinton Sk. Lycopene: Chemistry, biology and implications for human health and disease. Nutr Rev. 1998; 56(2):32-51.

van Het Hof KH, West CE, Weststrate JA, Hautvast JG. Dietary factors that affect the bioavailability of carotenoids. J Nutr. 2000; 130(3):503-6.

Paetau I, Khachik F, Brown ED, Beecher GR, Kramer TR, Chittams J, et al. Chronic ingestion of lycopene-rich tomato juice or lycopene supplements significantly increases plasma concentrations of lycopene and related tomato carotenoids in

humans. Am J Clin Nutr. 1998; 68(6):1187-95.

Boileau TW, Boileau AM, Erdman Jr JW. Bioavailability of all-trans and cis-isomers of lycopene. Exp Biol Med. 2002; 227(10):914-9.

Boileau AC, Merchen NR, Wasson K, Atkinson CA, Erdman JW Jr. Cis-lycopene, is more bioavailable than trans-lycopene in vitro and in vivo in lymph-cannulated ferrets. J Nutr. 1999; 129(6): 1176-81.

Cozzolino SMF. Biodisponibilidade de nutrientes. In: Fatores que interferem na biodisponibilidade de vitamina A e carotenóides. São Paulo: Manole; 2005. p.229-36.

Rodriguez-Amaya DB. Latin American food sources of carotenoids. Arch Latinoamer Nutr. 1999; 49(3):74-84S1.

Willcox JK, Catignani GL, Lazarus S. Tomatoes and cardiovascular health. Crit Rev Food Sci Nutr. 2003; 43(1):1-18.

-Rêgo ER, Finger FL, Casali VW, Cardoso AA. Inheritance of fruit color and pigment changes in a yellow tomato (Lycopersicon esculentum Mill) mutant. Genet Mol Biol. 1999; 22(1):1-8.

Gartner C, Stahl W, Sies H. Lycopene is more bioavailable from tomato paste than from fresh tomatoes. Am J Clin Nutr. 1997; 66(1):116-22.

; Richelle M, Bortlik K, Liardet S, Hager C, Lambelet P, Baur M, et al. A food-based formulation provides lycopene with the same bioavailability to humans as that from tomato paste. J Nutr. 2002; 132(3): 404-8.

Amaya-Farfan J, Domene SMA, Padovani RM. DRI: síntese comentada das novas propostas sobre recomendações nutricionais para antioxidantes. Rev Nutr. 2001; 14(2):71-8.

Naves MMV. Beta-caroteno e câncer. Rev Nutr. 1998; 11(2):99-115.

Ziegler RG, Colavito EA, Hartge P, McAdams MJ, Schoenberg JB, Mason TJ, et al. Importance of alpha-carotene e beta-carotene, and other phytochemicals in the etiology of lung cancer. J Nat Cancer Inst. 1996; 88(9):612-5.

Mellet W, Deckardt K, Gembardt C, Schulte S, van Ravenzwaay B, Slesinski R. Thirteen-week oral toxicity study of synthetic lycopene products in rats. Food Chem Toxicol. 2002; 40(11):1581-8.

Hoppe PP, Kramer K, van den Berg H, Steenge G, van Vliet T. Synthetic and tomato-based lycopene have identical bioavailability in humans. Eur J Nutr. 2003; 42(5):272-8.

Paetau I, Rao D, Wiley ER, Brown ED, Clevidence BA. Carotenoids in human buccal cells after 4 wk of supplementation with tomato juice or lycopene supplements. Am J Clin Nutr. 1999; 70(4):490-4.

Böhm V, Bitsch R. Intestinal absorption of lycopene from different matrices and interactions to other carotenoids, the lipid status, and the antioxidant capacity of human plasma. Eur J Nutr. 1999; 38(3):118-25.

Allen CM, Smith AM, Clinton SK, Schwartz SJ. Tomato consumption increases lycopene isomer concentrations in breast milk and plasma of lactating women. JADA. 2002; 102:1257-62.

Weisburger JH. Lycopene and tomato products in health promotion. Exp Biol Med. 2002; 227(10):924-7.

Rield J, Linseisen J, Hoffmann J, Wolfram G. Some dietary fibers reduce the absorption of carotenoids in women. J Nutr. 1999; 129(12):2170-6.

Shi J, Maguer ML. Lycopene in tomatoes:chemical and physical properties affect by food processing. Crit Rev Biotech. 2000; 20(4):293-334.

Hoffmann J, Linseisen, Rield J, Wolfram G. Dietary fiber reduces the antioxidative effect of a carotenoid and alpha-tocopherol mixture on LDL oxidation ex vivo in humans. Eur J Nutr. 1999; 38(6):278-85.

Tyssandier V, Cardinault N, Caris-Veyrat C, Amiot MJ, Grolier P, Bouteloup C, et al. Vegetable-borne lutein, lycopene, and beta-carotene compete for incorporation into chylomicrons, with no adverse effect on the medium-term (3-wk) plasma status of carotenoids in humans. Am J Clin Nutr. 2002; 75(3):526-34.

Johnson EJ, Qin J, Krinsky NI, Russell RM. Ingestion by men of a combined dose of beta-carotene but improves that of lycopene. J Nutr. 1997; 127(9): 1833-7.

Published

2023-09-19

How to Cite

MORITZ, B. ., & Cardoso TRAMONTE, V. L. . (2023). Bioavailability of lycopene. Brazilian Journal of Nutrition, 19(2). Retrieved from https://seer.sis.puc-campinas.edu.br/nutricao/article/view/9787